Eisai Gets Japan Clearance For Cervical-Dystonia Treatment
This article was originally published in PharmAsia News
Executive Summary
Eisai's NerBloc Intramuscular Injection (rimabotulinumtoxinB) has been cleared for marketing in Japan for treating cervical dystonia